𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detection of UV-induced activation of NF-κB in a recombinant human cell line by means of Enhanced Green Fluorescent Protein (EGFP)

✍ Scribed by Christine E. Hellweg; Christa Baumstark-Khan

Publisher
Springer-Verlag
Year
2007
Tongue
English
Weight
432 KB
Volume
46
Category
Article
ISSN
0301-634X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Suppression of NF-κB-dependent gene expr
Suppression of NF-κB-dependent gene expression by a hexamethylene bisacetamide-inducible protein HEXIM1 in human vascular smooth muscle cells
✍ Rika Ouchida; Masatoshi Kusuhara; Noriaki Shimizu; Tetsuya Hisada; Yuichi Makino 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB

## Abstract **Background:** Neointima formation is a characteristic feature of atherosclerosis and post‐angioplasty restenosis, in which various soluble factors and mechanical injury stimulate signalling pathways in vascular smooth muscle cells (VSMC), promoting their migration and proliferation, a

Nuclear factor-κB, induced in human carc
Nuclear factor-κB, induced in human carcinoma cell line A2780 by the new anthracycline men 10755, is devoid of transcriptional activity
✍ Grazia Camarda; Monica Binaschi; Carlo A. Maggi; Cristina Goso 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 552 KB

## Abstract The new disaccharide anthracycline MEN 10755 induces activation of both NF‐κB and p53 transcription factors in A2780 cells. Nevertheless, pharmacologic inhibition of NF‐κB activation does not modify the sensitivity of A2780 cells to MEN 10755 treatment. To better characterize the role o

CD40-CD40 ligand interactions in human m
CD40-CD40 ligand interactions in human microglia induce CXCL8 (interleukin-8) secretion by a mechanism dependent on activation of ERK1/2 and nuclear translocation of nuclear factor-κB (NFκB) and activator protein-1 (AP-1)
✍ Teresa G. D'Aversa; Eliseo A. Eugenin; Joan W. Berman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 971 KB

## Abstract CXCL8 is a CXC chemokine that recruits leukocytes to sites of inflammation. Expression of CXCL8 in the CNS has been demonstrated in neuroinflammatory diseases, including human immunodeficiency virus (HIV‐1) encephalitis, but the mechanism of secretion of this chemokine is not fully unde